Gilead Sciences, Inc. vs Regents of the University of Minnesota

Decision Denying Petitioner's Request for Rehearing of Decision Denying Institution

Order Denying POP Request

Notification of Receipt of POP Request

Ex. 3003

Petitioner's Request for Rehearing

Victor E. Marquez et al., HI-1 Reverse Transcriptase Can Discriminate between Two Conformationally Locked Carbocyclic AZT Triphosphate Analogues, J. AM. CHEM. SOC. 120:2780-89 (1998) ("Marquez V")

Victor E. Marquez et al., Nucleosides with a Twist. Can Fixed Forms of Sugar Ring Pucker Influence Biological Activity in Nucleosides and Oligonucleotides?, J.MED. CHEM. 39:3739-47 (1996) ("Marquez IV")

Victor E. Marquez et al., Experimental and Structural Evidence that Herpes 1 Kinase and Cellular DNA Polymerase(s) Discriminate on the Basis of Sugar Puckering, J. AM. CHEM. SOC. 126:543-549 (2004) ("Marquez VI")

DECISION Denying Institution of Inter Partes Review

Petitioner's Authorized Table of Supplemental Authority

Patent Owner's Response to Petitioner's Notice of Ranking Petitions

Petitioner's Notice

Conduct of the Proceeding 37 C.F.R. ¿¿ 42.5

ORDER Granting Patent Owner's Motion to Substitute Lead Counsel

Patent Owner's Unopposed Motion to Substitute Lead Counsel

Patent Owner's Second Updated Mandatory Notices

Patent Owner's Updated Power of Attorney

Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents ("DHHS 2004")

Chu 2003

Hachiya et al. 2001

King et al. 2002

HIV/AIDS Historical Time Line 1995-1999

Daluge et al. 1997

U.S. Patent No. 6,703,396

U.S. Patent No. 5,047,407

Meier et al. 1999

Perno et al. 1989

Secrist et al. 2008

Leary Nov. 1995

FDA Letter regarding NDA for Viramune June 21, 1996

Moyle et al. 1996

Volberding 1995

Label from SUSTIVA Sept. 22, 1998

De Clerq 1995

Loudon 1995

Marquez et al. 1993 ("Marquez III")

Patent Owner's Preliminary Response

Denying Patent Owner's Motion to Dismiss

Patent Owner's Notice of Denial of Petition for Cert in Regents of the University of Minnesota v. LSI Corp.

PANEL CHANGE ORDER Conduct of the Proceedings 37 C.F.R. ¿¿ 42.5

Transcript of August 20, 2019 Conference Call

Patent Owner's Notice of Filing Transcript of August 20, 2019 Conference Call

Decision - 37 C.F.R. 42.71(b)

Exhibit 3001

Exhibit 3002

Petitioner¿¿¿s Fourth Amended Mandatory Notices

Petitioner's Third Amended Mandatory Notices

Decision Denying Petitioner's Request for Rehearing

January 26, 2018 Email Chain Between Counsel for Petitioner and Counsel for Patent Owner

Petitioner's Request for Rehearing

Preliminary Amendment, U.S. Patent Application No. 14/229,292, (Mar. 31, 2014)

Order, Regents of the University of Minnesota v. Gilead Sciences, Inc., Civil Action No. 0:16-cv-02915-SRN-HB, D.I. 139 (D. Minn. Jun. 9, 2017)

Stipulated Case Management Statement, Regents of the University of Minnesota v. Gilead Sciences, Inc., 17-cv-6056-VC, D.I. 275 (N.D. Cal. Jan. 2, 2018)

January 26 Email from Counsel for Patent Owner to Board and Counsel for Petitioner

January 28, 2018 Email from Counsel for Petitioner to Board and Counsel for Patent Owner

Stipulation and Proposed Order to Exclude Filings From IPR Proceedings, Regents of the Univ. of Calif. v. St. Jude Medical, LLC (N.D. Cal. Feb. 2, 2018)

Order, Regents of the University of Minnesota v. AT&T Mobility LLC (D. Minn. May 19, 2017)

Gilead's Motion to Stay Pending Inter Partes Review, Regents of the University of Minnesota v. Gilead Sciences, Inc., 17-cv-6056-VC, D.I. 297 (N.D. Cal. Feb. 7, 2018)

Petitioner's Third Amended Exhibit List

Conduct of the Proceeding

Petitioner's Second Amended Mandatory Notices

Patent Owner's Updated Mandatory Notices

Patent Owner Notice of Filing Transcript of October 24, 2017 Conference Call

Transcript of October 24, 2017 Conference Call

Decision Petitioner's Motions for Pro Hac Vice Admission of Nevin M. Gewertz, Adam K. Mortara, J. Scott McBride, and Robert S. Schwartz

Order - Conduct of the Proceeding - 37 CFR 42.5

Patent Owner's Reply in Support of Motion to Dismiss

Gilead Sciences, Inc. Opposition to Regents of the University of Minnesota's Motion to Dismiss

Patent Owner's Motion to Dismiss

University of Minnesota Charter

University of Minnesota's Consolidated Financial Statements (2015 & 2016)

Gilead Sciences, Inc.'s Answer to Plaintiff's Complaint for Patent Infringement

Patent Assignment

Petitioner's Submission of Transcript

Transcript of Sept. 11, 2017 Conference Call

Petitioner's First Amended Mandatory Notices

Petitioner's Second Amended Exhibit List

Petitioner's Motion For Admission Pro Hac Vice Of Nevin M. Gewertz Under 37 C.F.R. 42.10(c)

Declaration of Nevin M. Gewertz

Petitioner's Motion For Admission Pro Hac Vice Of Adam K. Mortara Under 37 C.F.R. 42.10(c)

Declaration of Adam K. Mortara

Petitioner's Motion For Admission Pro Hac Vice Of J. Scott McBride Under 37 C.F.R. 42.10(c)

Declaration of J. Scott McBride

Petitioner's Motion For Admission Pro Hac Vice Of Robert S. Schwartz Under 37 C.F.R. 42.10(c)

Declaration of Robert S. Schwartz

Petitioner's First Amended Exhibit List

Notice of Accord Filing Date

Patent Owner Mandatory Notices

Patent Owner Power of Attorney

Notice of Allowability, U.S. Patent Application Serial No. 14/229,292 (May 23, 2014)

Nicolas Foloppe & Alexander D. MacKerell, Jr., Conformational Properties of the Deoxyribose and Ribose Moieties of Nucleic Acids: A Quantum Mechanical Study, 102(34) J. Phys. Chem. B (1998)

Complaint, Regents of the Univ. of Minn. v. Gilead Sciences, Inc., Civil Action No. 0:16-cv-02915-SRN-HB (D. Minn., Aug. 29, 2016)

Victor E. Marquez et al., Rapid Communications: 2', 3'-Dideoxy-2'-Fluo-Ara-A. An Acid-Stable Purine Nucleoside Active Against Human Immunodeficiency Virus (HIV), 36(17) Biochemical Pharmacology (1987)

Stephen G. Withers et al., 2-Deoxy-2'-fluoro-D-glycosyl Fluorides, 263(17) J. Bio. Chem. (1988)

Victor E. Marquez et al., Acid-stable 2'-Fluoro Purine Dideoxynucleosides as Active Agents Against HIV, 33 J Med. Chem. (1990)

U.S. Patent No. 8,815,830

U.S. Patent No. 6,475,985

Tokumi Maruyama et al., Synthesis and Anti-HIV Activity of 6-Substituted Purine 2'-Deoxy-2'Fluororibosides, 13(1-3) Nucleosides & Nucleotides (1994) ("Maruyama")

Yoshiko Sato et al., Synthesis and Hypnotic and Anti-Human Immunodeficiency Virus-1 Activities of N3-Substituted 2'-Deoxy-2'-fluorouridines, 42(3) Chem. Pharm. Bull. (1994) ("Sato")

Track One Grant, U.S. Patent Application Serial No. 14/229,292 (May 6, 2014)

Declaration of David MacMillan, Ph.D.

Curriculum Vitae of David MacMillan, Ph.D.

Piet Herdewijn et al., Synthesis of Nucleosides Fluorinated in the Sugar Moiety. The Application of Diethylaminosulfur Trifluoride to the Synthesis of Fluorinated Nucleosides, 8(1) Nucleosides & Nucleotides (1989) ("Herdewijn")

D.L. Mayers et al., Anti-human immunodeficiency virus 1 (HIV-1) activities of 3-deazaadenosine analogs: Increased potency against 3'-azido-3'-deoxythymidine resistant HIV-1 strains, 92 Proc. Nat'l Acad. Sci. (1995)

Carston E. Wagner et al., Aromatic Amino Acid Phosphoramidate Di- and Triesters of 3'-Azido-3'-Deoxythymidine (AZT) Are Non-toxic Inhibitors of HIV-1 Replication, 5(16) Bioorganic & Med. Chem. Letters (1995)

Edward J. McIntee et al., Probing the Mechanism of Action and Decomposition of Amino Acid Phosphomonoester Amidates of Antiviral Nucleoside Prodrugs, 40 J. Med. Chem. (1997)

Kiyoshi Bannai et al., Synthesis of Chemically Stable Prostacyclin Analogs, 39(22) Tetrahedron (1983)

Robert H. Abeles & Theodore A. Alston, Minireview: Enzyme Inhibition by Fluoro Compounds, 265(28) J. Bio. Chem. (1990)

Fahmi Himo & Per E.M. Siegbahn, Quantum Chemical Studies of Radical-Containing Enzymes, 103 Chem. Rev. (2003)

Petition for Inter Partes Review of U.S. Patent No. 8,815,830

Petitioner's Power of Attorney